PDA/FDA Joint Regulatory Conference 2024
GMP: Leading with Quality and Integrity
Registration Options
Individual Registration
Group Registration
Celebrate the 33rd annual PDA/FDA Joint Regulatory Conference this September!
This CGMP conference will emphasize the role of effective quality systems in ensuring an ongoing state of control throughout the product lifecycle by vigilantly managing risks to manufacturing and quality. The vital role of robust quality systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management are emphasized as fundamental to CGMP compliance.
Case studies presented throughout the conference will provide practical insights and illustrate how sustainable compliance establishes the foundation for quality and supply consistency. International collaboration efforts to improve quality and benefit consumers will also be highlighted.
Program Planning Committee
- Milind Ganjawala, U.S. FDA (Co-Chair)
- Janeen Skutnik-Wilkinson, Moderna (Co-Chair)
- Denyse Baker, Eli Lilly and Company
- Paul Balcer, U.S. FDA
- Tara Gooen Bizjak, U.S. FDA
- Francesco Cicirello, BioNTech
- Dan DeCiero, U.S. FDA
- Nicole Deschamps, GSK
- Becky Dowd, U.S. FDA
- Mary Farbman, Merck & Co., Inc.
- Irving Ford, Adaptimmune
- Rick Friedman, U.S. FDA
- Marc Glogovsky, ValSource, Inc.
- Andy Hopkins, AbbVie Inc.
- Mai Huynh, U.S. FDA
- Al Kentrup, Takeda
- Patrick Lynch, U.S. FDA
- Ingrid Markovic, U.S. FDA
- Ken Nolan, U.S. FDA
- Erika Pfeiler, U.S. FDA
- Jackie Veivia-Panter, BioCentriq
- Lorraine Wood, U.S. FDA
Contact
Program Inquiries
Exhibition/Sponsorship Inquiries
Training Course Inquiries
Registration Customer Care
More information coming soon.
GROUP REGISTRATION DISCOUNT: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.
GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.
CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].
Day 1
MONDAY, 09 SEPTEMBER
08:00 - 10:00 | P1: Opening Plenary |
10:00 - 10:45 | Networking Break in the Exhibit Area
10:45 – 12:30 | P2: Center Office Updates The global regulatory landscape is evolving. How will the U.S. FDA continue to optimize its strategies and actions to accomplish its mission to safeguard the quality, safety, and effectiveness of medicines for patients, even with current manufacturing and supply challenges? After introductory presentations on current Center activities, your questions will be posed to executive management from various FDA Centers! In a roundtable format, the conversation will focus on these issues that are often cross-cutting across different centers and relevant to the entire pharmaceutical space. |
10:45 | CBER Updates 11:00 | CDER Updates 11:15 | CVM Updates 11:30 | ORA Updates 11:45 | Q&A |
12:30 - 14:00 | Lunch on Own
14:00 - 15:30 | Concurrent Sessions |
A1: Proactive vs. Reactive Compliance and Addressing Symptoms Signals Early B1: Updates in Pharmaceutical CGMP Guidance and Policy C1: Selecting a Supplier: Manufacturing Performance and Data Integrity |
15:30 – 16:15 | Networking Break in the Exhibit Area
16:15 - 17:45 | Concurrent Sessions |
A2: CGMP and Data Integrity: Identifying and Filling the Gaps B2: Sterile Manufacturing Facilities and Quality Risk Management: Current Issues and Solutions C2: Review of Notable Investigations and Recalls |
19:00 – 22:00 | Grand Opening Reception
Day 2
TUESDAY, 10 SEPTEMBER
07:15 - 08:15 | Breakfast Sessions |
Breakfast 1: Effective Quality Systems Breakfast 2: Microbiology Breakfast 3: Disaster Recovery Planning Breakfast 4: Dealing with Particulates in ATMPs |
08:30 – 10:15 | P3: Compliance Office Updates Featuring Office of Compliance leaders from the U.S. FDA Centers and Office of Regulatory Affairs, this session continues as one of the highlights of the Conference. In a roundtable format, FDA's top leaders in compliance and enforcement will describe their programs, initiatives, and recent actions related to inspections and compliance. Current regulatory challenges and FDA's current enforcement strategy for a wide array of medical products will be addressed. This is a great opportunity for you to understand FDA's thinking and expectations for industry compliance. In addition, there will be ample time for the audience to ask questions of FDA's senior leadership. |
08:30 | CBER Compliance Updates 08:45 | CDER Compliance Updates 09:00 | CVM Compliance Updates 09:15 | ORA Compliance Updates 09:30 | Q&A |
10:15 – 11:00 | Networking Break in the Exhibit Area
11:00 - 12:30 | Concurrent Sessions |
A3: Strategic Communication: A Blueprint for Preventing Aging Facility Pitfalls B3: Quality Enabling Behaviors C3: Cybersecurity Hygiene in Pharma: Lessons from the Digital Battlegrounds |
12:30 – 14:00 | Lunch on Own
14:00 - 15:30 | Concurrent Sessions |
A4: The Importance of Independence and Authority for the Quality Unit B4: CGMP Considerations for Implementation of Emerging Technologies: Modeling for Control Strategy and Process Validation C4: De-Risking Your Quality Control Laboratory |
15:30 – 16:15 | Networking Break and Passport Drawing in the Exhibit Area
16:15 - 17:45 | Concurrent Sessions |
A5: Expanding Quality Ownership Beyond the Quality Department: How to Engrain It Across the Organization B5: Innovations in GMP Compliance: Regulatory Perspectives on Embracing Digital Technologies C5: Improving Auditing Programs: Going Beyond a Checkbox Approach |
Day 3
WEDNESDAY, 11 SEPTEMBER
07:15 - 08:15 | Breakfast Sessions |
Breakfast 5: Platform Technologies Development for ATMPs and Vaccines: GMP and CMC Considerations Breakfast 6: AI in the GMP Space Breakfast 7: X-Ray Technology |
08:30 – 10:00 | P4: Current GMP Compliance Trends and Topics This "can't miss" session will include presentations from CDER and CBER and will provide more than just the "Top Ten 483 observations." Participants will gain an understanding of the most recent trends from violative inspections and enforcement actions. This session routinely provides several key topics for attendees to consider and take back for discussion with their team members and colleagues. |
08:30 | CDER Updates 08:55 | CBER Updates 09:20 | Q&A |
10:00 – 10:30 | Networking Break
10:30 – 12:00 | P5: Operationalizing Quality Risk Management and Knowledge Management |
12:15 – 13:15 | Lunch with the Regulators Bring questions for U.S. FDA investigators, reviewers, and compliance officers to this lunch Q&A session that will allow for direct input and will provide you with insights regarding inspection trends and center initiatives. |
13:30 - 15:00 | P6: Closing Plenary |
Become a Sponsor
Interested in becoming a sponsor? Learn about opportunities and benefits.
Request InformationBecome an Exhibitor
Interested in becoming an exhibitor? Learn about opportunities and benefits.
Request InformationPLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.
The Westin, DC Downtown
999 9th Street, NWWashington, DC 20001, United States
Individual reservations cancelled within seventy-two (72) hours prior to arrival will forfeit one night’s room deposit. Individuals will be responsible for payment of their own cancellation fees.
Discover the vibrant heart of the city at the new Westin Washington, DC Downtown—an energizing gathering place bursting with fresh ideas. Immerse yourself in the allure of iconic experiences, just steps away from the family-friendly hotel in Washington, D.C.. From the National Mall to Chinatown, Capital One Arena to CityCenterDC, the best of the city awaits outside our doors. Unwind in our inviting guest rooms, featuring the renowned Heavenly® Bed. Ignite your passion in our expansive 10,000 sq. ft. fitness center, the largest in Washington, D.C. Indulge in locally sourced culinary delights that will invigorate your senses. With over 70,000 sq. ft. of flexible meeting space, including a 19,000 sq. ft. grand ballroom, we cater to a variety of gatherings. Our complete transformation has given rise to inspiring spaces, where Westin guests thrive, finding productivity and rejuvenation in perfect harmony.
Additional Hotel Information
- Rate: $331 + taxes/fees
- Room Block Open Date: 01 May 2024
- Cut-off date: 24 Sep 2024